Health Topics guide

Cancer Screening Basics

Cancer screening means checking for cancer, or for changes that could become cancer, in people who do not have symptoms. The goal is to find problems early, when treatment is often more effective.

Last updated 3 sources

At a Glance

  • Screening is for people without symptoms; symptoms are evaluated differently, with diagnostic tests.
  • Well-established screening tests exist for breast, cervical, colorectal, and, for certain people, lung cancer.
  • Recommendations depend on age, sex, family history, and other risk factors.
  • Groups such as the US Preventive Services Task Force (USPSTF) publish recommendations that are updated over time.
  • Screening has benefits and possible harms, which are commonly discussed with a clinician.

What It Is

Cancer screening tests look for cancer before a person has any symptoms. Some tests, such as colonoscopy and cervical screening, can also find precancerous changes that can be removed before they turn into cancer.

A screening test is different from a diagnostic test. If a screening result is abnormal, more tests, such as imaging or a biopsy, are usually needed to find out whether cancer is actually present.

Expert groups review research to decide which screening tests help people live longer or healthier lives, and at what ages. Recommendations may differ slightly between organizations and change as new evidence becomes available. Individual screening plans are decided together with a healthcare professional.

Common Terminology

Screening test
A test done in people without symptoms to look for early signs of a disease.
Diagnostic test
A test done to find the cause of symptoms or to follow up on an abnormal screening result.
False positive
A result that suggests cancer may be present when it is not, which can lead to more testing and worry.
False negative
A result that appears normal even though cancer is present.
Overdiagnosis
Finding a cancer that would never have caused symptoms or harm during a person's lifetime.
Biopsy
Removal of a small tissue sample to examine under a microscope, which is usually needed to confirm cancer.
Low-dose CT (LDCT)
A CT scan using a lower amount of radiation, used for lung cancer screening in certain higher-risk people.

Why Screening Is Done

Screening programs aim to reduce deaths and illness from certain cancers.

  • To find cancer at an earlier stage, when it is often easier to treat.
  • To find and remove precancerous growths, such as colon polyps or abnormal cervical cells.
  • To identify people who need closer follow-up based on their results.
  • To support people at higher risk, such as those with a strong family history or certain inherited gene changes, who may follow different screening schedules.

Common Screening Tests

The following describes commonly recommended screening tests in general terms. Specific age ranges and intervals vary by organization and individual risk.

  • Breast cancer: mammography, an X-ray of the breast; the USPSTF recommends screening every two years for women ages 40 to 74 at average risk.
  • Cervical cancer: Pap tests, HPV tests, or both, generally recommended for women and people with a cervix from about ages 21 to 65.
  • Colorectal cancer: options include colonoscopy and stool-based tests; the USPSTF recommends screening for adults ages 45 to 75.
  • Lung cancer: yearly low-dose CT is recommended by the USPSTF for certain adults ages 50 to 80 with a significant smoking history.
  • Prostate cancer: the PSA blood test is an option that men ages 55 to 69 are encouraged to discuss with a clinician, since benefits and harms are closely balanced.
  • Skin and other cancers: evidence for routine screening in the general population is more limited, though some people at higher risk may have regular checks.

Factors That Shape Screening Recommendations

General recommendations are a starting point. Several factors can change what is appropriate for a particular person.

  • Age, since the balance of benefits and harms changes over a lifetime.
  • Family history of cancer, especially in close relatives or at younger ages.
  • Inherited gene changes, such as BRCA1, BRCA2, or Lynch syndrome.
  • Personal history of cancer, precancerous findings, or certain conditions such as inflammatory bowel disease.
  • Smoking history, which is central to lung cancer screening eligibility.
  • Overall health and life expectancy, which affect whether screening is likely to be helpful.

Benefits and Limitations

Screening can save lives, but no test is perfect. Understanding both sides is part of shared decision-making.

  • Benefits can include earlier detection, simpler treatment, and lower risk of dying from certain cancers.
  • False positive results can lead to extra tests, procedures, and anxiety.
  • False negative results can occur, so new symptoms are still worth reporting even after a normal screening test.
  • Overdiagnosis can lead to treatment of cancers that would not have caused harm.
  • Some tests carry small risks of their own, such as bleeding or bowel injury with colonoscopy, or radiation exposure with imaging.
  • An abnormal result usually means more testing is needed, not that cancer has been confirmed.

When Professional Care May Be Discussed

Screening decisions are commonly made during routine checkups.

  • Reaching an age when a screening test is generally recommended is a common time to discuss screening options.
  • A family history of cancer or known inherited gene change is often discussed with a clinician, sometimes along with genetic counseling.
  • Symptoms such as a new lump, unexplained bleeding, or lasting changes in bowel habits are evaluated with diagnostic tests rather than routine screening.
  • Abnormal screening results are reviewed with a clinician to plan follow-up.
  • Older adults often discuss with a clinician when it may be reasonable to stop certain screening tests.

Questions to Ask a Healthcare Professional

General questions people often find useful to bring to an appointment:

  • What is the difference between a screening test and a diagnostic test?
  • Which cancer screening tests are generally recommended at different ages?
  • How does family history change general screening recommendations?
  • What are the different options for colorectal cancer screening, and how do they compare?
  • What happens after an abnormal screening result?
  • What are false positives and overdiagnosis, and why do they matter?
  • How often are screening recommendations updated, and who makes them?

Sources

This guide was written in plain language from the following authoritative references.

  1. Cancer Screening Overview — National Cancer Institute (NCI)
  2. Recommendation Topics — U.S. Preventive Services Task Force (USPSTF)
  3. NHS screening — NHS

Last updated October 8, 2026. FreeDoc guides are general educational information and are not a substitute for care from a qualified professional.